Back
#1
18.5%
Top 0.6%
18.5%
Top 0.2%
8.1%
Top 74%
6.2%
Top 7%
5.2%
Top 54%
5.2%
Top 0.4%
4.3%
Top 0.3%
4.0%
Top 1%
4.0%
Top 0.9%
4.0%
Top 35%
2.0%
Top 9%
2.0%
Top 11%
1.4%
Top 3%
1.2%
Top 0.7%
1.0%
Top 62%
1.0%
Top 11%
1.0%
Top 8%
0.7%
Top 12%
0.7%
Artificial Intelligence quantified prostate specific membrane antigen imaging in metastatic castrate-resistant prostate cancer patients treated with Lutetium-177-PSMA-617
2025-08-12
oncology
Title + abstract only
View on medRxiv
Show abstract
PURPOSEThe VISION study1 found that Lutetium-177 (177Lu)-PSMA-617 ("Lu-177") improved overall survival in metastatic castrate resistant prostate cancer (mCRPC). We assessed whether artificial intelligence enhanced PSMA imaging in mCRPC patients starting Lu-177 could identify those with better treatment outcomes. PATIENTS AND METHODSWe conducted a single site, tertiary center, retrospective cohort study in 51 consecutive mCRPC patients treated 2022-2024 with Lu-177. These patients had received m...
Predicted journal destinations
1
Frontiers in Oncology
34 training papers
2
Cancers
57 training papers
3
Clinical Cancer Research
22 training papers
4
PLOS ONE
1737 training papers
5
eLife
262 training papers
6
Scientific Reports
701 training papers
7
BMC Cancer
21 training papers
8
International Journal of Molecular Sciences
39 training papers
9
British Journal of Cancer
22 training papers
10
Cancer Medicine
17 training papers
11
Nature Communications
483 training papers
12
JAMA Network Open
125 training papers
13
Cureus
64 training papers
14
Diagnostics
36 training papers
15
EBioMedicine
21 training papers
16
BMJ Open
553 training papers
17
Frontiers in Immunology
140 training papers
18
PeerJ
46 training papers
19
iScience
74 training papers